Prostate cancer GTV delineation with biparametric MRI and 68Ga-PSMA-PET: comparison of expert contours and semi-automated methods

被引:11
|
作者
Hearn, Nathan [1 ,2 ,3 ]
Blazak, John [4 ]
Vivian, Philip [4 ]
Vignarajah, Dinesh [1 ,2 ]
Cahill, Katelyn [1 ]
Atwell, Daisy [1 ,2 ,3 ]
Lagopoulos, Jim [3 ,5 ]
Min, Myo [1 ,2 ,3 ]
机构
[1] Sunshine Coast Univ Hosp, Dept Radiat Oncol, Birtinya, Australia
[2] ICON Canc Ctr, Maroochydore, Australia
[3] Univ Sunshine Coast, Sippy Downs, Qld, Australia
[4] Sunshine Coast Univ Hosp, Dept Med Imaging, Birtinya, Australia
[5] Univ Sunshine Coast, Sunshine Coast Mind & Neurosci Thompson Inst, Birtinya, Australia
来源
BRITISH JOURNAL OF RADIOLOGY | 2021年 / 94卷 / 1119期
关键词
APPARENT DIFFUSION-COEFFICIENT; VOLUME DELINEATION; GLEASON SCORE; PET/CT; DIFFERENTIATION; LEVEL;
D O I
10.1259/bjr.20201174
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: The optimal method for delineation of dominant intraprostatic lesions (DIL) for targeted radiotherapy dose escalation is unclear. This study evaluated interobserver and intermodality variability of delineations on biparametric MRI (bpMRI), consisting of T-2 weighted (T2W) and diffusion-weighted (DWI) sequences, and Ga-68-PSMA-PET/CT; and compared manually delineated GTV contours with semi-automated segmentations based on quantitative thresholding of intraprostatic apparent diffusion coefficient (ADC) and standardised uptake values (SUV). Methods: 16 patients who had bpMRI and PSMA-PET scanning performed prior to any treatment were eligible for inclusion. Four observers (two radiation oncologists, two radiologists) manually delineated the DIL on: (1) bpMRI (GTV(MRI)), (2) PSMA-PET (GTV(PSMA)) and (3) co-registered bpMRI/PSMA-PET (GTV(Fused)) in separate sittings. Interobserver, intermodality and semi-automated comparisons were evaluated against consensus Simultaneous Truth and Performance Level Estimation (STAPLE) volumes, created from the relevant manual delineations of all observers with equal weighting. Comparisons included the Dice Similarity Coefficient (DSC), mean distance to agreement (MDA) and other metrics. Results: Interobserver agreement was significantly higher (p < 0.05) for GTV(PSMA) (DSC: 0.822, MDA: 1.12 mm) and GTV(Fused) (DSC: 0.787, MDA: 1.34 mm) than for GTV(MRI) (DSC: 0.705, MDA 2.44 mm). Intermodality agreement between GTV(MRI) and GTV(PSMA) was low (DSC: 0.440, MDA: 4.64 mm). Agreement between semi-automated volumes and consensus GTV was low for MRI (DSC: 0.370, MDA: 8.16 mm) and significantly higher for PSMA-PET (0.571, MDA: 4.45 mm, p < 0.05). Conclusion: Ga-68-PSMA-PET appears to improve interobserver consistency of DIL localisation vs bpMRI and may be more viable for simple quantitative delineation approaches; however, more sophisticated approaches to semi-automatic delineation factoring for patient- and disease-related heterogeneity are likely required. Advances in knowledge: This is the first study to evaluate the interobserver variability of prostate GTV delineations with co-registered bpMRI and Ga-68-PSMA-PET.
引用
收藏
页数:11
相关论文
共 50 条
  • [1] PSMA PET/CT vs MRI for GTV delineation in prostate cancer: a comparison with histology
    Zamboglou, C.
    Drendel, V.
    Jilg, C. A.
    Rischke, H. C.
    Teresa, B., I
    Krauss, T.
    Werner, M.
    Bock, M.
    Langer, M.
    Meyer, P. T.
    Grosu, A. L.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S294 - S294
  • [2] Comparison of Ga-68 PSMA PET/CT and Ga-68 PSMA PET/MRI with biparametric prostate MRI in terms of location and extension of primary prostate gland tumour
    Besli, L. Uslu
    Asa, S.
    Bakir, B.
    Sayman, H.
    Sager, S.
    Khosroshahi, B. Razavi
    Guner, E.
    Demirdag, C.
    Demir, M.
    Uslu, I.
    Sonmezoglu, K.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S535 - S536
  • [3] Comparative analysis of the accuracy in the delineation of intraprostatic carcinoma lesions by using of hybrid image 68Ga-PSMA-PET/MRI, as well as 18F-PSMA-PET and 68Ga-PSMA-PET complemented with multiparametric MRI
    Scobioala, S.
    Kittel, C.
    Wolters, H.
    Oertel, M.
    Kroeger, K.
    Schaefers, M.
    Rahbar, K.
    Eich, H. T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S91 - S91
  • [4] Epididymal Metastasis of Prostate Cancer Detected With 68Ga-PSMA-PET/CT
    Serfling, Sebastian
    Luther, Achim
    Kosmala, Aleksander
    Bluemel, Christina
    CLINICAL NUCLEAR MEDICINE, 2016, 41 (10) : 792 - 793
  • [5] Comparison of 68Ga-PSMA PET/CT and multiparametric MRI for staging of high-risk prostate cancer68Ga-PSMA PET and MRI in prostate cancer
    Tulsyan, Shruti
    Das, Chandan J.
    Tripathi, Madhavi
    Seth, Amlesh
    Kumar, Rajeev
    Bal, Chandrasekhar
    NUCLEAR MEDICINE COMMUNICATIONS, 2017, 38 (12) : 1094 - 1102
  • [6] Comparison between 68Ga-PSMA-PET/CT and mpMRI for radiotherapy planning in primary prostate cancer
    Spohn, S.
    Jaegle, C.
    Bettermann, A. S.
    Kiefer, S.
    Jilg, C. A.
    Kranz-Rudolph, J.
    Fassbender, T. F.
    Bronsert, P.
    Nicolay, N. H.
    Bock, M.
    Ruf, J.
    Benndorf, M.
    Grosu, A. L.
    Zamboglou, C.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S104 - S104
  • [7] Influence of a 68Ga-PSMA-PET/CT scan on therapeutic decisions for prostate cancer
    Linke, F.
    Bluemel, C.
    Sangster, K.
    Surholt, C.
    Hermann, K.
    Schribel, A.
    Wester, H. -J.
    Buck, A. K.
    Becker, A.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2016, 192 : 53 - 54
  • [8] 68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer
    Damjanovic, Jonathan
    Janssen, Jan-Carlo
    Prasad, Vikas
    Diederichs, Gerd
    Walter, Thula
    Brenner, Winfried
    Makowski, Marcus R.
    CANCER IMAGING, 2019, 19 (1)
  • [9] 68Ga-PSMA-PET/CT for the evaluation of liver metastases in patients with prostate cancer
    Jonathan Damjanovic
    Jan-Carlo Janssen
    Vikas Prasad
    Gerd Diederichs
    Thula Walter
    Winfried Brenner
    Marcus R. Makowski
    Cancer Imaging, 19
  • [10] Integration of 68Ga-PSMA-PET/CT in Radiotherapy Planning for Prostate Cancer Patients
    Onal, Cem
    Torun, Nese
    Akyol, Fadil
    Guler, Ozan Cem
    Hurmuz, Pervin
    Yildirim, Berna Akkus
    Caglar, Meltem
    Reyhan, Mehmet
    Ozyigit, Gokhan
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (09) : E510 - E516